Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic Using Two Hour Neoral Monitoring.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Ciclosporin (Primary) ; Mycophenolate sodium (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms COBACAM
- 10 Jun 2017 Biomarkers information updated
- 05 Jan 2017 Planned End Date changed from 1 Jan 2017 to 1 Oct 2015.
- 05 Jan 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2015.